Eximore is developing ophthalmic drug delivery products. The company’s initial development is a non-invasive, novel sustained-release delivery system targeting glaucoma. |
Eximore is developing ophthalmic drug delivery products. The company’s initial development is a non-invasive, novel sustained-release delivery system targeting glaucoma. |